Endovia Health Sciences, Inc.
EDVANYSECIK 1553788Consumer staplesFiscal year ends Dec 31
Reports and events: 236 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2717:26 ET | S-1 | Registration statement | 0001731122-26-001378 |
| 2026-10-2716:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-26-001375 |
| 2026-10-1516:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-26-001347 |
| 2026-10-0616:10 ET | 8-K | 3.02 Unregistered sale of equity | 0001731122-26-001320 |
| 2026-10-0516:31 ET | DEF 14A | Proxy statementPeriod 2026-10-05 | 0001731122-26-001316 |
| 2026-10-0516:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001312 |
| 2026-09-2416:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-26-001281 |
| 2026-09-2216:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001271 |
| 2026-08-3116:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001173 |
| 2026-08-2816:33 ET | 8-K | 3.02 Unregistered sale of equity | 0001731122-26-001170 |
| 2026-08-2616:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-26-001152 |
| 2026-08-2508:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001144 |
| 2026-08-2108:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001120 |
| 2026-08-2016:06 ET | S-1/A | Registration statement, amended | 0001731122-26-001117 |
| 2026-08-2009:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001731122-26-001114 |
| 2026-08-1916:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001731122-26-001102 |
| 2026-08-1208:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001047 |
| 2026-08-1116:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-26-001040 |
| 2026-08-0716:04 ET | S-1 | Registration statement | 0001731122-26-001026 |
| 2026-08-0508:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-001020 |
| 2026-08-0416:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-26-001012 |
| 2026-07-3016:10 ET | 8-K/A | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000990 |
| 2026-07-2916:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000982 |
| 2026-07-2116:32 ET | 8-K | 1.01 Entry into a material agreement | 0001731122-26-000962 |
| 2026-07-1616:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-26-000950 |
| 2026-07-1409:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000936 |
| 2026-07-1316:30 ET | 8-K | 1.01 Entry into a material agreement | 0001731122-26-000933 |
| 2026-07-1016:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001731122-26-000929 |
| 2026-07-0909:00 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000927 |
| 2026-07-0616:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-26-000917 |
| 2026-07-0608:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000910 |
| 2026-06-2616:45 ET | 8-K | 3.02 Unregistered sale of equity | 0001731122-26-000895 |
| 2026-06-1508:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000853 |
| 2026-06-1217:01 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0001731122-26-000851 |
| 2026-06-1216:30 ET | S-1 | Registration statement | 0001731122-26-000846 |
| 2026-06-0416:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001731122-26-000817 |
| 2026-06-0308:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000810 |
| 2026-05-2016:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001731122-26-000769 |
| 2026-05-1508:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000730 |
| 2026-05-0516:08 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000668 |
| 2026-04-3016:31 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001731122-26-000640 |
| 2026-04-2716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001731122-26-000614 |
| 2026-04-2416:30 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001731122-26-000612 |
| 2026-04-2116:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-26-000603 |
| 2026-04-1516:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001731122-26-000577 |
| 2026-03-1216:06 ET | 8-K | 7.01 Regulation FD disclosure | 0001731122-26-000385 |
| 2026-03-0508:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000335 |
| 2026-02-0608:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000183 |
| 2026-01-3016:05 ET | 8-K | 3.02 Unregistered sale of equity | 0001731122-26-000156 |
| 2026-01-2710:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-26-000130 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. Listed shows no prices and gives no investment advice.